111 Property, Plant, and Equipment 2018-2024 | YI

111 property, plant, and equipment from 2018 to 2024. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
111 Annual Property, Plant, and Equipment
(Millions of US $)
2024 $5
2023 $5
2022 $7
2021 $13
2020 $7
2019 $4
2018 $3
2017 $3
111 Quarterly Property, Plant, and Equipment
(Millions of US $)
2024-12-31 $5
2024-09-30 $4
2024-06-30 $4
2024-03-31 $4
2023-12-31 $5
2023-09-30 $5
2023-06-30 $6
2023-03-31 $7
2022-12-31 $7
2022-09-30 $9
2022-06-30 $10
2022-03-31 $12
2021-12-31 $13
2021-09-30 $12
2021-06-30 $12
2021-03-31 $8
2020-12-31 $7
2020-09-30 $4
2020-06-30 $4
2020-03-31 $4
2019-12-31 $4
2019-09-30 $3
2019-06-30 $3
2019-03-31 $3
2018-09-30 $3
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.067B $1.973B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.234B 52.81
Hims & Hers Health (HIMS) United States $12.982B 134.88
Tempus AI (TEM) United States $10.012B 0.00
IRhythm Technologies (IRTC) United States $4.465B 0.00
Inspire Medical Systems (INSP) United States $4.309B 67.32
Privia Health (PRVA) United States $2.902B 198.33
Enovis (ENOV) United States $1.848B 10.30
Clover Health Investments (CLOV) United States $1.791B 0.00
Schrodinger (SDGR) United States $1.498B 0.00
Phreesia (PHR) United States $1.456B 0.00
Omnicell (OMCL) United States $1.281B 22.59
Azenta (AZTA) United States $1.258B 58.47
10x Genomics (TXG) United States $1.024B 0.00
Fulgent Genetics (FLGT) United States $0.618B 0.00
Butterfly Network (BFLY) United States $0.534B 0.00
Talkspace (TALK) United States $0.486B 145.25
Veradigm (MDRX) United States $0.476B 0.00
Claritev (CTEV) United States $0.473B 0.00
Standard BioTools (LAB) United States $0.395B 0.00
TruBridge (TBRG) United States $0.363B 805.00
Nyxoah SA (NYXH) Belgium $0.274B 0.00
Health Catalyst (HCAT) United States $0.260B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.195B 0.00
EUDA Health Holdings (EUDA) Singapore $0.141B 0.00
Pulmonx (LUNG) United States $0.126B 0.00
American Well (AMWL) United States $0.116B 0.00
MDxHealth SA (MDXH) Belgium $0.099B 0.00
CareCloud (CCLD) United States $0.086B 3.27
Outset Medical (OM) United States $0.067B 0.00
P3 Health Partners (PIII) United States $0.056B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
Retrieve Medical Holdings (RMHI) United States $0.051B 0.00
Zepp Health (ZEPP) Netherlands $0.038B 0.00
Zhongchao (ZCMD) China $0.033B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.015B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Streamline Health Solutions (STRM) United States $0.009B 0.00
Movano (MOVE) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00